Physician profile
James C Hansen
NPI 1114128048
$1,323.96
in general payments reported to CMS, 2019-2025
10 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2022: $700 · 2023: $81.79 · 2024: $198 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $921.97 | 2019-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Cvrx, INC. | $127.50 | 2022 | |
| Abbott Laboratories | $107.53 | 2019-2025 | Ensite |
| Medtronic, INC. | $36.28 | 2023-2025 | Micra, Linq II |
| Novartis Pharmaceuticals Corporation | $31.49 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $28.33 | 2025 | Lifevest |
| Heartflow, INC. | $25.95 | 2024 | |
| Esperion Therapeutics, INC. | $18.28 | 2025 | Nexletol |
| Irhythm Technologies, INC. | $13.95 | 2024 | Zio Xt Patch, Zio Monitor |
| E.R. Squibb & Sons, L.L.C. | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.